DVA

#704
DaVita Inc. Common Stock
194.4 1 USD
-1.38%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
193.96
195.97
Intervallo Annuale
101.00
202.58
Variazione giornaliera
-1.38%
Variazione Mensile
+28.82%
Variazione di 6 mesi
+63.00%
Variazione Annuale
+43.39%
Chiusura Precedente
197.1 4
Open
195.9 7
Minimo
193.9 6
High
195.9 7
Volume
385
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 12.48 B
  • Employee 78 K
  • Founded 1992
  • CEO Javier J. Rodriguez
  • Website www.davita.com
  • Headquarter Delaware, United States
  • FIGI BBG000MQ1SN9
  • Industry Strutture Mediche
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
14.35
Rapporto prezzo/fatturato
0.82

DaVita Inc. Common Stock

DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.

Notizie